Karyopharm’s mixed myelofibrosis data; Rezolute to seek FDA approval despite trial failurenews2026-03-24T14:23:33+00:00March 24th, 2026|Endpoints News|
Q&A: Controversial embryo editing entrepreneur Cathy Tie on her new startupnews2026-03-24T14:10:54+00:00March 24th, 2026|Endpoints News|
XO Health to expand its alternative health plan nationwidenews2026-03-24T13:00:57+00:00March 24th, 2026|Endpoints News|
Triangle Health raises $4M as people turn to AI to understand their healthnews2026-03-24T13:00:11+00:00March 24th, 2026|Endpoints News|
Biotech investors set to meet with key congressional panelnews2026-03-24T12:00:02+00:00March 24th, 2026|Endpoints News|
Apnimed set to exit sleep disorder joint venture with Shionogi for $100M upfrontnews2026-03-24T11:19:25+00:00March 24th, 2026|Endpoints News|
Gilead bets $1.68B upfront on Ouro Medicines’ autoimmune program, with Galapagos expected to pitch innews2026-03-24T10:41:57+00:00March 24th, 2026|Endpoints News|
Merck partners with Flagship startup Quotient to search for genetic clues to IBDnews2026-03-24T10:00:17+00:00March 24th, 2026|Endpoints News|
Immutrin secures $86M for antibody programnews2026-03-24T07:00:02+00:00March 24th, 2026|Endpoints News|
Novartis to invest $480M in China following AstraZeneca and Lilly pledgesnews2026-03-23T18:40:53+00:00March 23rd, 2026|Endpoints News|
